These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33474865)

  • 1. Changes in Type 2 Biomarkers After Anti-IL5 Treatment in Patients With Severe Eosinophilic Asthma.
    Jang JH; Woo SD; Lee Y; Kim CK; Shin YS; Ye YM; Park HS
    Allergy Asthma Immunol Res; 2021 Mar; 13(2):330-338. PubMed ID: 33474865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Levels of Eosinophil-Derived Neurotoxin: A Biomarker for Asthma Severity in Adult Asthmatics.
    Lee Y; Lee JH; Yang EM; Kwon E; Jung CG; Kim SC; Choi Y; Cho YS; Kim CK; Park HS
    Allergy Asthma Immunol Res; 2019 May; 11(3):394-405. PubMed ID: 30912328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children.
    Kim HS; Yang HJ; Song DJ; Lee YJ; Suh DI; Shim JY; Yoo Y; Kim CK; Ahn YM; Kim JT
    Allergy Asthma Proc; 2022 Mar; 43(2):133-139. PubMed ID: 35317890
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum Eosinophil-Derived Neurotoxin Better Reflect Asthma Control Status Than Blood Eosinophil Counts.
    An J; Lee JH; Sim JH; Song WJ; Kwon HS; Cho YS; Moon HB; Kim CK; Kim TB
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2681-2688.e1. PubMed ID: 32304842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma.
    Gon Y; Ito R; Hattori T; Hiranuma H; Kumasawa F; Kozu Y; Endo D; Koyama D; Shintani Y; Eriko T; Soda K; Maruoka S; Hashimoto S
    Allergy Asthma Proc; 2015; 36(6):e113-20. PubMed ID: 26534742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma.
    Kalinauskaite-Zukauske V; Januskevicius A; Janulaityte I; Miliauskas S; Malakauskas K
    BMC Pulm Med; 2019 Aug; 19(1):158. PubMed ID: 31438916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of eosinophil derived neurotoxin with airway resistance in asthmatics.
    Badar A; Hussain MM; Saeed W; Aslam M
    J Pak Med Assoc; 2010 Feb; 60(2):97-101. PubMed ID: 20209693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
    Mansur AH; Srivastava S; Sahal A
    Respir Med; 2018 Oct; 143():31-38. PubMed ID: 30261989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductions in eosinophil biomarkers by benralizumab in patients with asthma.
    Pham TH; Damera G; Newbold P; Ranade K
    Respir Med; 2016 Feb; 111():21-9. PubMed ID: 26775606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of EDN levels in patients with asthma and correlation with FEV
    Kuai S; Zhao P
    Allergy Asthma Proc; 2023 Jul; 44(4):244-251. PubMed ID: 37480200
    [No Abstract]   [Full Text] [Related]  

  • 11. IgE sensitization to food allergens and airborne allergens in relation to biomarkers of type 2 inflammation in asthma.
    Patelis A; Alving K; Middelveld R; James A; Ono J; Ohta S; Izuhara K; Borres MP; Forsberg B; Janson C; Malinovschi A
    Clin Exp Allergy; 2018 Sep; 48(9):1147-1154. PubMed ID: 29746003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics.
    Takahashi K; Meguro K; Kawashima H; Kashiwakuma D; Kagami SI; Ohta S; Ono J; Izuhara K; Iwamoto I
    J Asthma; 2019 Mar; 56(3):236-243. PubMed ID: 29648484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.
    Kim KW; Lee KE; Kim ES; Song TW; Sohn MH; Kim KE
    Lung; 2007; 185(2):97-103. PubMed ID: 17393238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma.
    Soma T; Iemura H; Naito E; Miyauchi S; Uchida Y; Nakagome K; Nagata M
    Allergol Int; 2018 Sep; 67S():S3-S11. PubMed ID: 29754974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed airflow obstruction relates to eosinophil activation in asthmatics.
    Mogensen I; Alving K; Dahlen SE; James A; Forsberg B; Ono J; Ohta S; Venge P; Borres MP; Izuhara K; Janson C; Malinovschi A
    Clin Exp Allergy; 2019 Feb; 49(2):155-162. PubMed ID: 30365193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an automated ImmunoCAP research assay for eosinophil derived neurotoxin and its use in asthma diagnosis in children.
    Rydell N; Nagao M; Ekoff H; Sjölander A; Borres M; Fujisawa T
    Pract Lab Med; 2019 Nov; 17():e00138. PubMed ID: 31649990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of eosinophil-derived neurotoxin levels with asthma control status in patients with aspirin-exacerbated respiratory disease.
    Ban GY; Yang EM; Ye YM; Park HS
    Clin Transl Allergy; 2023 Mar; 13(3):e12229. PubMed ID: 36973950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
    Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
    Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in FeNO Levels Following IL5/IL5R-Targeting Therapies in Severe Asthma: A Case Series.
    Pelletier G; Godbout K; Boulay MÈ; Boulet LP; Morissette MC; Côté A
    J Asthma Allergy; 2022; 15():691-701. PubMed ID: 35615256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
    Liu T; Wu J; Zhao J; Wang J; Zhang Y; Liu L; Cao L; Liu Y; Dong L
    Respir Med; 2015 Nov; 109(11):1391-6. PubMed ID: 26459159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.